Literature DB >> 25633558

Free energy calculations of A(2A) adenosine receptor mutation effects on agonist binding.

Henrik Keränen1, Johan Åqvist, Hugo Gutiérrez-de-Terán.   

Abstract

A general computational scheme to evaluate the effects of single point mutations on ligand binding is reported. This scheme is applied to characterize agonist binding to the A2A adenosine receptor, and is found to accurately explain how point mutations of different nature affect the binding affinity of a potent agonist.

Mesh:

Substances:

Year:  2015        PMID: 25633558     DOI: 10.1039/c4cc09517k

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  9 in total

1.  Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.

Authors:  Thomas Coudrat; John Simms; Arthur Christopoulos; Denise Wootten; Patrick M Sexton
Journal:  PLoS Comput Biol       Date:  2017-11-13       Impact factor: 4.475

2.  The GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site.

Authors:  Anne Cathrine Nøhr; Willem Jespers; Mohamed A Shehata; Leonard Floryan; Vignir Isberg; Kirsten Bayer Andersen; Johan Åqvist; Hugo Gutiérrez-de-Terán; Hans Bräuner-Osborne; David E Gloriam
Journal:  Sci Rep       Date:  2017-04-25       Impact factor: 4.379

3.  Predicting Binding Affinities for GPCR Ligands Using Free-Energy Perturbation.

Authors:  Eelke B Lenselink; Julien Louvel; Anna F Forti; Jacobus P D van Veldhoven; Henk de Vries; Thea Mulder-Krieger; Fiona M McRobb; Ana Negri; Joseph Goose; Robert Abel; Herman W T van Vlijmen; Lingle Wang; Edward Harder; Woody Sherman; Adriaan P IJzerman; Thijs Beuming
Journal:  ACS Omega       Date:  2016-08-30

4.  Structure-Based Design of Potent and Selective Ligands at the Four Adenosine Receptors.

Authors:  Willem Jespers; Ana Oliveira; Rubén Prieto-Díaz; María Majellaro; Johan Åqvist; Eddy Sotelo; Hugo Gutiérrez-de-Terán
Journal:  Molecules       Date:  2017-11-10       Impact factor: 4.411

5.  Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists.

Authors:  Silvana Vasile; Anders Hallberg; Jessica Sallander; Mathias Hallberg; Johan Åqvist; Hugo Gutiérrez-de-Terán
Journal:  Biomolecules       Date:  2020-04-23

6.  Structural Basis of Inhibition of Human Insulin-Regulated Aminopeptidase (IRAP) by Benzopyran-Based Inhibitors.

Authors:  Sudarsana Reddy Vanga; Johan Åqvist; Anders Hallberg; Hugo Gutiérrez-de-Terán
Journal:  Front Mol Biosci       Date:  2021-04-01

7.  Deciphering conformational selectivity in the A2A adenosine G protein-coupled receptor by free energy simulations.

Authors:  Willem Jespers; Laura H Heitman; Adriaan P IJzerman; Eddy Sotelo; Gerard J P van Westen; Johan Åqvist; Hugo Gutiérrez-de-Terán
Journal:  PLoS Comput Biol       Date:  2021-11-24       Impact factor: 4.475

8.  Identification of V6.51L as a selectivity hotspot in stereoselective A2B adenosine receptor antagonist recognition.

Authors:  Xuesong Wang; Willem Jespers; Rubén Prieto-Díaz; Maria Majellaro; Adriaan P IJzerman; Gerard J P van Westen; Eddy Sotelo; Laura H Heitman; Hugo Gutiérrez-de-Terán
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

Review 9.  Recent Trends and Applications of Molecular Modeling in GPCR⁻Ligand Recognition and Structure-Based Drug Design.

Authors:  Xiaojing Yuan; Yechun Xu
Journal:  Int J Mol Sci       Date:  2018-07-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.